These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32447924)

  • 1. [Introduction of the Prediction model Risk Of Bias ASsessment Tool: a tool to assess risk of bias and applicability of prediction model studies].
    Chen R; Wang SF; Zhou JC; Sun F; Wei WW; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 May; 41(5):776-781. PubMed ID: 32447924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies.
    Wolff RF; Moons KGM; Riley RD; Whiting PF; Westwood M; Collins GS; Reitsma JB; Kleijnen J; Mallett S;
    Ann Intern Med; 2019 Jan; 170(1):51-58. PubMed ID: 30596875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appraising prediction research: a guide and meta-review on bias and applicability assessment using the Prediction model Risk Of Bias ASsessment Tool (PROBAST).
    de Jong Y; Ramspek CL; Zoccali C; Jager KJ; Dekker FW; van Diepen M
    Nephrology (Carlton); 2021 Dec; 26(12):939-947. PubMed ID: 34138495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence.
    Collins GS; Dhiman P; Andaur Navarro CL; Ma J; Hooft L; Reitsma JB; Logullo P; Beam AL; Peng L; Van Calster B; van Smeden M; Riley RD; Moons KG
    BMJ Open; 2021 Jul; 11(7):e048008. PubMed ID: 34244270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration.
    Moons KGM; Wolff RF; Riley RD; Whiting PF; Westwood M; Collins GS; Reitsma JB; Kleijnen J; Mallett S
    Ann Intern Med; 2019 Jan; 170(1):W1-W33. PubMed ID: 30596876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale validation of the prediction model risk of bias assessment Tool (PROBAST) using a short form: high risk of bias models show poorer discrimination.
    Venema E; Wessler BS; Paulus JK; Salah R; Raman G; Leung LY; Koethe BC; Nelson J; Park JG; van Klaveren D; Steyerberg EW; Kent DM
    J Clin Epidemiol; 2021 Oct; 138():32-39. PubMed ID: 34175377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining Bias and Reporting in Oral Health Prediction Modeling Studies.
    Du M; Haag D; Song Y; Lynch J; Mittinty M
    J Dent Res; 2020 Apr; 99(4):374-387. PubMed ID: 32028825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-Rater Agreement in Assessing Risk of Bias in Melanoma Prediction Studies Using the Prediction Model Risk of Bias Assessment Tool (PROBAST): Results from a Controlled Experiment on the Effect of Specific Rater Training.
    Kaiser I; Pfahlberg AB; Mathes S; Uter W; Diehl K; Steeb T; Heppt MV; Gefeller O
    J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical appraisal of the clinical applicability and risk of bias of the predictive models for mortality and recurrence in patients with oropharyngeal cancer: Systematic review.
    Palazón-Bru A; Mares-García E; López-Bru D; Mares-Arambul E; Folgado-de la Rosa DM; Carbonell-Torregrosa MLÁ; Gil-Guillén VF
    Head Neck; 2020 Apr; 42(4):763-773. PubMed ID: 31762119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic metareview of prediction studies demonstrates stable trends in bias and low PROBAST inter-rater agreement.
    Langenhuijsen LFS; Janse RJ; Venema E; Kent DM; van Diepen M; Dekker FW; Steyerberg EW; de Jong Y
    J Clin Epidemiol; 2023 Jul; 159():159-173. PubMed ID: 37142166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies.
    Kaiser I; Mathes S; Pfahlberg AB; Uter W; Berking C; Heppt MV; Steeb T; Diehl K; Gefeller O
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHARMS and PROBAST at your fingertips: a template for data extraction and risk of bias assessment in systematic reviews of predictive models.
    Fernandez-Felix BM; López-Alcalde J; Roqué M; Muriel A; Zamora J
    BMC Med Res Methodol; 2023 Feb; 23(1):44. PubMed ID: 36800933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reporting and Methods in Developing Prognostic Prediction Models for Metabolic Syndrome: A Systematic Review and Critical Appraisal.
    Zhang H; Shao J; Chen D; Zou P; Cui N; Tang L; Wang D; Ye Z
    Diabetes Metab Syndr Obes; 2020; 13():4981-4992. PubMed ID: 33364802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review finds risk of bias and applicability concerns for models predicting central line-associated bloodstream infection.
    Gao S; Albu E; Tuand K; Cossey V; Rademakers F; Van Calster B; Wynants L
    J Clin Epidemiol; 2023 Sep; 161():127-139. PubMed ID: 37536503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical appraisal of the prognostic predictive models for patients with sepsis: Which model can be applied in clinical practice?
    Beneyto-Ripoll C; Palazón-Bru A; Llópez-Espinós P; Martínez-Díaz AM; Gil-Guillén VF; de Los Ángeles Carbonell-Torregrosa M
    Int J Clin Pract; 2021 Aug; 75(8):e14044. PubMed ID: 33492724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QUAPAS: An Adaptation of the QUADAS-2 Tool to Assess Prognostic Accuracy Studies.
    Lee J; Mulder F; Leeflang M; Wolff R; Whiting P; Bossuyt PM
    Ann Intern Med; 2022 Jul; 175(7):1010-1018. PubMed ID: 35696685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction Model Risk-of-Bias Assessment Tool for coronary artery lesions in Kawasaki disease.
    Huang H; Dong J; Wang S; Shen Y; Zheng Y; Jiang J; Zeng B; Li X; Yang F; Ma S; He Y; Lin F; Chen C; Chen Q; Lv H
    Front Cardiovasc Med; 2022; 9():1014067. PubMed ID: 36312287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariable prediction models for health care spending using machine learning: a protocol of a systematic review.
    Huang AW; Haslberger M; Coulibaly N; Galárraga O; Oganisian A; Belbasis L; Panagiotou OA
    Diagn Progn Res; 2022 Mar; 6(1):4. PubMed ID: 35321760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of prediction tools to identify adult hospitalized patients at risk of drug-related problems: A systematic review of clinical prediction models and risk assessment tools.
    Deawjaroen K; Sillabutra J; Poolsup N; Stewart D; Suksomboon N
    Br J Clin Pharmacol; 2022 Feb; 88(4):1613-1629. PubMed ID: 34626130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A literature review of quality assessment and applicability to HTA of risk prediction models of coronary heart disease in patients with diabetes.
    Jiu L; Wang J; Javier Somolinos-Simón F; Tapia-Galisteo J; García-Sáez G; Hernando M; Li X; Vreman RA; Mantel-Teeuwisse AK; Goettsch WG
    Diabetes Res Clin Pract; 2024 Mar; 209():111574. PubMed ID: 38346592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.